Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula

• Published in: Scientific reports Vol. 13; no. 1; pp. 2669 - 6
• Main Authors: Suzuki, Tetsuya, Morioka, Shinichiro, Yamamoto, Kei, Saito, Sho, Iida, Shun, Teruya, Katsuji, Takasaki, Jin, Hojo, Masayuki, Hayakawa, Kayoko, Kutsuna, Satoshi, Miyamoto, Sho, Ozono, Seiya, Suzuki, Tadaki, Kodama, Eiichi N., Ohmagari, Norio
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 15.02.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/326/171/1281; 631/326/596/4130; 692/699/255; Air sampling; Cannula; Coronaviruses; COVID-19; COVID-19 - therapy; Gelatin; Humanities and Social Sciences; Humans; Mechanical ventilation; multidisciplinary; Nasopharynx; Noninvasive Ventilation - methods; Oxygen Inhalation Therapy - methods; Oxygenation; Respiratory Aerosols and Droplets; Respiratory Insufficiency - therapy; Ribonucleic acid; RNA; RNA viruses; SARS-CoV-2; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Viruses
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-29740-4

A high-flow nasal cannula (HFNC) therapy plays a significant role in providing respiratory support to critically ill patients with coronavirus disease 2019 (COVID-19); however, the dispersion of the virus owing to aerosol generation is a matter of concern. This study aimed to evaluate if HFNC disperses the virus into the air. Among patients with COVID-19 admitted to private rooms with controlled negative pressure, we enrolled those admitted within 10 days of onset and requiring oxygenation through a conventional nasal cannula or HFNC therapy. Of the 17 patients enrolled, we obtained 22 samples (11 in the conventional nasal cannula group and 11 in the HFNC group). Viral RNA was detected in 20 nasopharyngeal swabs, and viable viruses were isolated from three nasopharyngeal swabs. Neither viral RNA nor viable virus was detected in the air sample at 0.5 m regardless of the oxygen-supplementation device. We detected viral RNA in two samples in the conventional nasal cannula group but not in the HFNC therapy group in gelatin filters located 3 m from the patient and the surface of the ventilation. This study directly demonstrated that despite viral RNA detection in the nasopharynx, viruses may not be dispersed by HFNC therapy. This warrants further research to determine if similar results can be obtained under different conditions.